📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3). (2024)

First Author: Hazenberg P
Attributed to:  ICF: Pneumococcal vaccine to prevent transmission of serotype 3 pneumococcus funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2023-075948

PubMed Identifier: 38199622

Publication URI: http://europepmc.org/abstract/MED/38199622

Type: Journal Article/Review

Volume: 14

Parent Publication: BMJ open

Issue: 1

ISSN: 2044-6055